Correlation Between Virax Biolabs and Sidus Space
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Sidus Space at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Sidus Space into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Sidus Space, you can compare the effects of market volatilities on Virax Biolabs and Sidus Space and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Sidus Space. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Sidus Space.
Diversification Opportunities for Virax Biolabs and Sidus Space
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Virax and Sidus is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Sidus Space in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sidus Space and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Sidus Space. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sidus Space has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Sidus Space go up and down completely randomly.
Pair Corralation between Virax Biolabs and Sidus Space
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 0.74 times more return on investment than Sidus Space. However, Virax Biolabs Group is 1.35 times less risky than Sidus Space. It trades about 0.01 of its potential returns per unit of risk. Sidus Space is currently generating about 0.0 per unit of risk. If you would invest 690.00 in Virax Biolabs Group on December 16, 2024 and sell it today you would lose (553.00) from holding Virax Biolabs Group or give up 80.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Sidus Space
Performance |
| Timeline |
| Virax Biolabs Group |
| Sidus Space |
Virax Biolabs and Sidus Space Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Sidus Space
The main advantage of trading using opposite Virax Biolabs and Sidus Space positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Sidus Space can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sidus Space will offset losses from the drop in Sidus Space's long position.| Virax Biolabs vs. Revelation Biosciences | ||
| Virax Biolabs vs. Kiora Pharmaceuticals | ||
| Virax Biolabs vs. Quoin Pharmaceuticals Ltd | ||
| Virax Biolabs vs. Cardio Diagnostics Holdings |
| Sidus Space vs. Intelligent Living Application | ||
| Sidus Space vs. Quoin Pharmaceuticals Ltd | ||
| Sidus Space vs. Virax Biolabs Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |